mesalamine has been researched along with Shock, Septic in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 73-year-old woman developed ulcerative colitis with mesalazine intolerance a year ago." | 1.91 | [A case of ulcerative colitis with mesalazine intolerance complicated with agranulocytosis and septic shock during salazosulfapyridine administration]. ( Eizuka, K; Honta, S; Ikehata, A; Inomata, N; Masuo, T; Ono, S; Sekino, Y, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikehata, A | 1 |
| Honta, S | 1 |
| Sekino, Y | 1 |
| Masuo, T | 1 |
| Eizuka, K | 1 |
| Inomata, N | 1 |
| Ono, S | 1 |
| López-Iñiguez, A | 1 |
| Pérez-Gutiérrez, MT | 1 |
| Lambraño-Castillo, D | 1 |
| Sierra-Madero, JG | 1 |
2 other studies available for mesalamine and Shock, Septic
| Article | Year |
|---|---|
[A case of ulcerative colitis with mesalazine intolerance complicated with agranulocytosis and septic shock during salazosulfapyridine administration].
Topics: Aged; Agranulocytosis; Colitis, Ulcerative; Female; Humans; Mesalamine; Shock, Septic; Sulfasalazine | 2023 |
Necrotic lesion in an immunosuppressed patient.
Topics: Aged; Colitis, Ulcerative; Ecthyma; Fatal Outcome; Gangrene; Humans; Immunocompromised Host; Immunos | 2018 |